Evidence map›Paper›PMID 38792155›Full record

ArticleMolecules (Basel, Switzerland)2024

Photocatalytic Degradation of Quinolones by Magnetic MOFs Materials and Mechanism Study.

Hongchao Chang, Guangyao Xu, Xiantong Huang, Wei Xu, Fujuan Luo, Jiarong Zang, Xiaowei Lin, Rong Huang, Hua Yu, Binbin Yu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hongchao ChangSchool of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou 318000, China.
Guangyao XuSchool of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou 318000, China.
Xiantong HuangEcological Environment Testing Centre, Zaozhuang 277300, China.
Wei XuZhejiang Baima Lake Laboratory Co., Ltd., Hangzhou 310053, China.
Fujuan LuoSchool of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou 318000, China.
Jiarong ZangSchool of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou 318000, China.
Xiaowei LinSchool of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou 318000, China.
Rong HuangSchool of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou 318000, China.
Hua YuSchool of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou 318000, China.
Binbin YuSchool of Pharmaceutical and Chemical Engineering, Taizhou University, Taizhou 318000, China.

Funding

NNSF of China 22202146Zhejiang Provincial Natural Science Foundation of China LGG21B070001
6 · The paper itself

Abstract

With the rising incidence of various diseases in China and the constant development of the pharmaceutical industry, there is a growing demand for floxacin-type antibiotics. Due to the large-scale production and high cost of waste treatment, the parent drug and its metabolites constantly enter the water environment through domestic sewage, production wastewater, and other pathways. In recent years, the pollution of the aquatic environment by floxacin has become increasingly serious, making the technology to degrade floxacin in the aquatic environment a research hotspot in the field of environmental science. Metal-organic frameworks (MOFs), as a new type of porous material, have attracted much attention in recent years. In this paper, four photocatalytic materials, MIL-53(Fe), NH

Indexed as

Metal-Organic FrameworksQuinolonesWater Pollutants, ChemicalAnti-Bacterial AgentsCatalysisEnrofloxacinLightOfloxacinPhotochemical ProcessesPhotolysisAnti-Bacterial AgentsEnrofloxacinMetal-Organic FrameworksOfloxacinQuinolonesWater Pollutants, Chemicaldegradation mechanismsmagnetic MOFsphotocatalytic degradationquinolones

Identifiers

PMID38792155
PMCPMC11123774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.